Marksans Pharma raises Rs 372.40 crore in equity via conversion of warrants issued to OrbiMed and…
The warrants are converted at a price of Rs 74 per share, reflecting the promoter's and OrbiMed's commitment to the company
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
OrbiMed
Valneva secures new financing with Deerfield and OrbiMed
Valneva said it had agreed to increase the principal amount of its existing $60 million debt financing agreement with up to an…